Login to Your Account



Search

Search results

Pharma: Clinic roundup

Sanofi Pasteur, the vaccines division of Sanofi SA , of Paris, said the first of two pivotal phase III efficacy studies with its dengue vaccine candidate has achieved its primary clinical endpoint. The study showed a reduction of 56 percent of dengue ...

BioWorld Today - Staff - 2014-04-28 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Teva Pharmaceutical Industries Ltd. , of Jerusalem, said it enrolled the first patient in the Pride-HD study, a phase II trial designed to evaluate the impact of pridopidine, an oral, small molecule, on motor impairment in patients with Huntington's ...

BioWorld Today - Staff - 2014-04-24 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Eisai Co. Ltd. , of Tokyo, reported that Zonegran (zonisamide) was well tolerated and efficacious when used as an adjunctive treatment for partial epilepsy, with or without secondary generalization, in children between the ages of 6 and 17 for at lea ...

BioWorld Today - Staff - 2014-04-22 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Abbvie Inc. , of North Chicago, initiated a global phase III trial evaluating the safety and efficacy of veliparib (ABT-888) in patients with previously untreated locally advanced or metastatic squamous non-small-cell lung cancer (NSCLC). (B ...

BioWorld Today - Staff - 2014-04-15 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Dompe Group , of Milan, said it started a phase Ib/II study to assess the safety and potential efficacy of recombinant human nerve growth factor (rhNGF) eye drops in two doses vs. placebo. (BioWorld-Today-2014-04-04) ...

BioWorld Today - Staff - 2014-04-03 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Bayer HealthCare Pharmaceuticals Inc. , of Whippany, N.J., began enrollment in a trial studying Xofigo (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mil ...

BioWorld Today - Staff - 2014-04-02 23:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Forest Laboratories Inc ., of New York, and Gedeon Richter Plc , of Budapest, Hungary, reported positive top-line results from a global, randomized, placebo-controlled, fixed-dose, eight-week phase IIb trial evaluating the efficacy and safety of c ...

BioWorld Today - Staff - 2014-03-31 23:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc. , of New York, and Bristol-Myers Squibb Co. , also of New York, said results of a pre-specified subanalysis of the phase III ARISTOTLE trial assessing the effect of blood pressure control on outcomes as well as the treatment effect of ...

BioWorld Today - Staff - 2014-03-27 23:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc ., of New York, reported top-line results from a phase IIIB study evaluating the 24-month efficacy of Genotropin (somatropin) on the height in small-for-gestational-age children 24-30 months old. (BioWorld-Today-2014-03-27) ...

BioWorld Today - Staff - 2014-03-26 23:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc. , of New York, reported that PROFILE 1014, a phase III study testing anaplastic lymphoma kinase (ALK) inhibitor Xalkori (crizotinib) met its primary objective of significantly prolonging progression-free survival in previously untreated p ...

BioWorld Today - Staff - 2014-03-25 23:00 - 0 comments - 0 attachments